|
Interagency Serological Working Group
|
Committee, Work group, Advisory group, or Task Force
|
BARDA, CDC, FDA
|
NIAID
|
Coordinating influenza serological studies and capabilities across agencies.
|
|
Interagency Task Force on Military and Veterans Mental Health (ITF)
|
Committee, Work group, Advisory group, or Task Force
|
ACL, OS, SAMHSA
|
NIMH
|
Executive Order 13625, Improving Access to Mental Health Services for Veterans, Service Members, and Military Families, was released on August 31, 2012, and directed the Departments of Defense (DoD), Veterans Affairs (VA), and Health and Human Services (HHS) to ensure that Veterans, Service Members, and their families have access to needed mental health services and support. The Executive Order also established the Interagency Task Force on Military and Veterans Mental Health (ITF) and directed it to provide an annual review of agency actions, to define specific goals and metrics to aid in measuring progress, and make additional recommendations as appropriate to the President to improve mental health and substance use disorder treatment services for Veterans, Service Members, and their families. The ITF, co-chaired by the DoD Assistant Secretary for Health Affairs, the VA Under Secretary for Health, and the HHS Administrator for the Substance Abuse and Mental Health Services Administration, tracks and reports progress in executing all activities resulting from recommendations made pursuant to the Executive Order.
|
|
Interagency Task Force on the Arts and Human Development
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, SAMHSA
|
NICHD, NCCIH, NCI, NIA, NIMH, OD/DPCPSI/OBSSR
|
Beginning in 2011, the National Endowment for the Arts (NEA) has convened a Federal Interagency Task Force on the Arts and Human Development to encourage more and better research on how the arts can help people reach their full potential at all stages of life.
|
|
Interagency Workgroup on Coordinating Opportunities for Evaluating Dolutegravir and Neural Tube Defects Association
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NICHD
|
This is a group addressing the potential association of dolutegravir and neural tube defects and associated research and policy issues.
|
|
Interagency Working Group in the Glycosciences
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIGMS, NCI, NICHD, NIDCR, NIDDK
|
This group meets annually to identify synergies, discuss progress on the development of national standards for carbohydrates, and exchange information on the glycosciences being pursued at each agency
|
|
Interagency working group on Biological Data Sharing
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIGMS, NCI
|
The working group will identify the diverse types of biological and clinical data, define specific needs and best practices for storing, managing, curating, archiving, and maintaining the confidentiality and integrity of these data, and define agency roles and responsibilities for addressing research and policy (exclusive of regulatory) priority gaps to enable data sharing. The working group will develop a road map to enable robust sharing and maximize reuse of data, identifying opportunities for interagency coordination, and academic, industrial, and international partnerships.
|
|
Interagency Working Group on Open Science
|
Committee, Work group, Advisory group, or Task Force
|
ACL, AHRQ, CDC, FDA, OS
|
OD/OSP, NLM, OD/OER
|
Advance Federal efforts to support open science by increasing access to and use of the results of Federally funded research and development.
|
|
Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC)
|
Committee, Work group, Advisory group, or Task Force
|
CMS, SAMHSA
|
NIMH
|
In December 2016, the 21st Century Cures Act was signed into law (Public Law 114‐255). Through this Act, the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC) was established to address the needs of adults with serious mental illness (SMI) and children and youth with serious emotional disturbance (SED) and their families. The Assistant Secretary for Mental Health and Substance Use and other federal members of the ISMICC works across the Department of Health and Human Services (HHS) and other federal departments so that Americans with SMI and SED are able to improve their lives and receive the highest possible standard of care—care that is deeply informed by knowledge of science and medicine. The ISMICC includes representatives from eight federal departments that support programs that address the needs of people with SMI and SED, and is informed and strengthened by the participation of non‐federal members, including national experts on health care research, mental health providers, advocates, people with living with mental health conditions, and their families and caregivers. This cross‐sector, public‐private partnership provides a unique opportunity to share and generate solutions to the problems facing the mental health system. The ISMICC seeks to support a system where individuals with SMI or SED are able to engage effectively with a range of treatment and recovery support services that promote opportunities for people to live well in their communities. A central charge of this committee is to submit two reports to Congress, the first no later than one year after the enactment of the Act, and the second five years following enactment. The ISMICC has five priority areas and corresponding workgroups for these priority areas. Representatives from NIMH sit on each of these workgroups.
|
|
Interferon Lambda (IFN-?): Disease Impact and Therapeutic Potential
|
Meeting/ Workshop
|
FDA
|
NCI, NIAID, NIDDK
|
Scientists from the National Cancer Institute (NCI) and Food and Drug Administration (FDA) collaborated to organize a meeting that was held at the NIH on October 25-26, 2018. The purpose of the meeting was to promote research on IFN-λs by enhancing interdisciplinary communication.
|
|
International Cancer Control Partnership
|
Other
|
CDC
|
NCI
|
The National Cancer Institute and the Union for International Cancer Control convened global partners including the Centers for Disease Control and Prevention (CDC) to cooperate in assisting countries to develop and implement quality cancer plans linked to Non-communicable Disease (NCD) control. This International Cancer Control Partnership, ICCP, believes that prioritizing cancer is critical to reaching the “25x25” goal. ICCP partners will assist countries by: (1) Creating a searchable database of current cancer control plans from around the globe; (2) Performing analysis of gaps and highlighting priority areas for inclusion in plans; (3) Training appropriate personnel to develop plans with targets and evaluation strategies; (4) Providing planners with relevant existing materials and tools; and (5) Offering technical assistance. ICCP partners will use their collective state, country, and regional-level planning experience to guide plan development and implementation and will ensure planners utilize effective, evidence-based strategies to help meet the global NCD targets.
|